Celldex Therapeutics, Inc. Research and Development Expense
Celldex Therapeutics, Inc. (CLDX) reported Research and Development Expense of $67.54 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-06
- Celldex Therapeutics, Inc. research and development expense for the quarter ending 2026-06-30 was $67.54M, a 24.63% increase year-over-year.
- Celldex Therapeutics, Inc. research and development expense for the quarter ending 2026-03-31 was $73.00M, a 38.75% increase year-over-year.
- Celldex Therapeutics, Inc. research and development expense for the quarter ending 2025-12-31 was $75.33M, a 60.49% increase year-over-year.
- Celldex Therapeutics, Inc. research and development expense for the quarter ending 2025-09-30 was $62.93M, a 39.03% increase year-over-year.
- Celldex Therapeutics, Inc. research and development expense for fiscal 2025 was $245.07M, a 49.85% increase from fiscal 2024.
- Celldex Therapeutics, Inc. research and development expense for fiscal 2024 was $163.55M, a 38.59% increase from fiscal 2023.
- Celldex Therapeutics, Inc. research and development expense for fiscal 2023 was $118.01M, a 43.46% increase from fiscal 2022.
- Celldex Therapeutics, Inc. research and development expense for fiscal 2022 was $82.26M, a 54.30% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $67.54M 10-Q · filed 2026-08-06 | $140.54M 10-Q · filed 2026-08-06 | $215.88M derived: sum of 3 quarters · filed 2026-08-06 | $278.81M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $73.00M 10-Q · filed 2026-05-07 | $148.33M derived: sum of 2 quarters · filed 2026-05-07 | $211.26M derived: sum of 3 quarters · filed 2026-05-07 | $265.46M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $75.33M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $138.26M derived: sum of 2 quarters · filed 2026-02-25 | $192.46M derived: sum of 3 quarters · filed 2026-08-06 | $245.07M 10-K · filed 2026-02-25 |
| 2025-09-30 | $62.93M 10-Q · filed 2025-11-10 | $117.13M derived: sum of 2 quarters · filed 2026-08-06 | $169.74M 10-Q · filed 2025-11-10 | $216.68M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $54.20M 10-Q · filed 2026-08-06 | $106.81M 10-Q · filed 2026-08-06 | $153.75M derived: sum of 3 quarters · filed 2026-08-06 | $199.01M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $52.61M 10-Q · filed 2026-05-07 | $99.55M derived: sum of 2 quarters · filed 2026-05-07 | $144.82M derived: sum of 3 quarters · filed 2026-05-07 | $184.50M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $46.94M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $92.20M derived: sum of 2 quarters · filed 2026-02-25 | $131.89M derived: sum of 3 quarters · filed 2026-02-25 | $163.55M 10-K · filed 2026-02-25 |
| 2024-09-30 | $45.26M 10-Q · filed 2025-11-10 | $84.95M derived: sum of 2 quarters · filed 2025-11-10 | $116.61M 10-Q · filed 2025-11-10 | $147.04M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $39.69M 10-Q · filed 2025-08-07 | $71.35M 10-Q · filed 2025-08-07 | $101.77M derived: sum of 3 quarters · filed 2026-02-25 | $136.31M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $31.66M 10-Q · filed 2025-05-08 | $62.09M derived: sum of 2 quarters · filed 2026-02-25 | $96.62M derived: sum of 3 quarters · filed 2026-02-25 | $122.87M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $30.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $64.96M derived: sum of 2 quarters · filed 2026-02-25 | $91.21M derived: sum of 3 quarters · filed 2026-02-25 | $118.01M 10-K · filed 2026-02-25 |
| 2023-09-30 | $34.53M 10-Q · filed 2024-11-06 | $60.79M derived: sum of 2 quarters · filed 2024-11-06 | $87.58M 10-Q · filed 2024-11-06 | $110.48M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $26.25M 10-Q · filed 2024-08-08 | $53.05M 10-Q · filed 2024-08-08 | $75.95M derived: sum of 3 quarters · filed 2025-02-27 | $97.52M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $26.80M 10-Q · filed 2024-05-06 | $49.70M derived: sum of 2 quarters · filed 2025-02-27 | $71.27M derived: sum of 3 quarters · filed 2025-02-27 | $92.00M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $22.90M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $44.47M derived: sum of 2 quarters · filed 2025-02-27 | $65.20M derived: sum of 3 quarters · filed 2025-02-27 | $82.26M 10-K · filed 2025-02-27 |
| 2022-09-30 | $21.57M 10-Q · filed 2023-11-02 | $42.30M derived: sum of 2 quarters · filed 2023-11-02 | $59.36M 10-Q · filed 2023-11-02 | $74.04M derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-06-30 | $20.73M 10-Q · filed 2023-08-08 | $37.79M 10-Q · filed 2023-08-08 | $52.47M derived: sum of 3 quarters · filed 2024-02-26 | $66.02M derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-03-31 | $17.06M 10-Q · filed 2023-05-04 | $31.73M derived: sum of 2 quarters · filed 2024-02-26 | $45.29M derived: sum of 3 quarters · filed 2024-02-26 | $57.65M derived: sum of 4 quarters · filed 2024-02-26 |
| 2021-12-31 | $14.68M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $28.23M derived: sum of 2 quarters · filed 2024-02-26 | $40.59M derived: sum of 3 quarters · filed 2024-02-26 | $53.31M 10-K · filed 2024-02-26 |
| 2021-09-30 | $13.56M 10-Q · filed 2022-11-09 | $25.91M derived: sum of 2 quarters · filed 2022-11-09 | $38.63M 10-Q · filed 2022-11-09 | $49.06M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $12.36M 10-Q · filed 2022-08-08 | $25.08M 10-Q · filed 2022-08-08 | $35.50M derived: sum of 3 quarters · filed 2023-02-28 | $46.21M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $12.72M 10-Q · filed 2022-05-05 | $23.14M derived: sum of 2 quarters · filed 2023-02-28 | $33.85M derived: sum of 3 quarters · filed 2023-02-28 | $43.56M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $10.43M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $21.13M derived: sum of 2 quarters · filed 2023-02-28 | $30.84M derived: sum of 3 quarters · filed 2023-02-28 | $42.53M 10-K · filed 2023-02-28 |
| 2020-09-30 | $10.71M 10-Q · filed 2021-11-09 | $20.41M derived: sum of 2 quarters · filed 2021-11-09 | $32.11M 10-Q · filed 2021-11-09 | $42.45M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $9.71M 10-Q · filed 2021-08-05 | $21.40M 10-Q · filed 2021-08-05 | $31.74M derived: sum of 3 quarters · filed 2022-02-28 | $42.84M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $11.70M 10-Q · filed 2021-05-06 | $22.03M derived: sum of 2 quarters · filed 2022-02-28 | $33.13M derived: sum of 3 quarters · filed 2022-02-28 | $43.22M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $10.34M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $21.44M derived: sum of 2 quarters · filed 2022-02-28 | $31.52M derived: sum of 3 quarters · filed 2022-02-28 | $42.67M 10-K · filed 2022-02-28 |
| 2019-09-30 | $11.10M 10-Q · filed 2020-11-05 | $21.18M derived: sum of 2 quarters · filed 2020-11-05 | $32.33M 10-Q · filed 2020-11-05 | $43.54M derived: sum of 4 quarters · filed 2021-03-29 |
| 2019-06-30 | $10.08M 10-Q · filed 2020-08-06 | $21.23M 10-Q · filed 2020-08-06 | $32.44M derived: sum of 3 quarters · filed 2021-03-29 | $44.36M derived: sum of 4 quarters · filed 2021-03-29 |
| 2019-03-31 | $11.15M 10-Q · filed 2020-05-06 | $22.36M derived: sum of 2 quarters · filed 2021-03-29 | $34.28M derived: sum of 3 quarters · filed 2021-03-29 | $55.72M derived: sum of 4 quarters · filed 2021-03-29 |
| 2018-12-31 | $11.21M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $23.13M derived: sum of 2 quarters · filed 2021-03-29 | $44.57M derived: sum of 3 quarters · filed 2021-03-29 | $66.45M 10-K · filed 2021-03-29 |
| 2018-09-30 | $11.92M 10-Q · filed 2019-11-12 | $33.37M derived: sum of 2 quarters · filed 2019-11-12 | $55.24M 10-Q · filed 2019-11-12 | $78.70M derived: sum of 4 quarters · filed 2020-03-26 |
| 2018-06-30 | $21.45M 10-Q · filed 2019-08-07 | $43.32M 10-Q · filed 2019-08-07 | $66.79M derived: sum of 3 quarters · filed 2020-03-26 | $88.70M derived: sum of 4 quarters · filed 2020-03-26 |
| 2018-03-31 | $21.88M 10-Q · filed 2019-05-07 | $45.34M derived: sum of 2 quarters · filed 2020-03-26 | $67.25M derived: sum of 3 quarters · filed 2020-03-26 | $92.25M derived: sum of 4 quarters · filed 2020-03-26 |
| 2017-12-31 | $23.46M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $45.38M derived: sum of 2 quarters · filed 2020-03-26 | $70.38M derived: sum of 3 quarters · filed 2020-03-26 | $96.17M 10-K · filed 2020-03-26 |
| 2017-09-30 | $21.91M 10-Q · filed 2018-11-07 | $46.91M derived: sum of 2 quarters · filed 2018-11-07 | $72.71M 10-Q · filed 2018-11-07 | $97.27M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-06-30 | $25.00M 10-Q · filed 2018-08-08 | $50.79M 10-Q · filed 2018-08-08 | $75.35M derived: sum of 3 quarters · filed 2019-03-07 | $100.36M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-03-31 | $25.79M 10-Q · filed 2018-05-10 | $50.35M derived: sum of 2 quarters · filed 2019-03-07 | $75.36M derived: sum of 3 quarters · filed 2019-03-07 | $101.07M derived: sum of 4 quarters · filed 2019-03-07 |
| 2016-12-31 | $24.56M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $49.57M derived: sum of 2 quarters · filed 2019-03-07 | $75.28M derived: sum of 3 quarters · filed 2019-03-07 | $102.73M 10-K · filed 2019-03-07 |
| 2016-09-30 | $25.01M 10-Q · filed 2017-11-07 | $50.72M derived: sum of 2 quarters · filed 2017-11-07 | $78.17M 10-Q · filed 2017-11-07 | $102.07M derived: sum of 4 quarters · filed 2018-03-07 |
| 2016-06-30 | $25.71M 10-Q · filed 2017-08-08 | $53.16M 10-Q · filed 2017-08-08 | $77.06M derived: sum of 3 quarters · filed 2018-03-07 | $101.71M derived: sum of 4 quarters · filed 2018-03-07 |
| 2016-03-31 | $27.45M 10-Q · filed 2017-05-09 | $51.35M derived: sum of 2 quarters · filed 2018-03-07 | $76.00M derived: sum of 3 quarters · filed 2018-03-07 | $102.49M derived: sum of 4 quarters · filed 2018-03-07 |
| 2015-12-31 | $23.90M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | $48.56M derived: sum of 2 quarters · filed 2018-03-07 | $75.05M derived: sum of 3 quarters · filed 2018-03-07 | $100.17M 10-K · filed 2018-03-07 |
| 2015-09-30 | $24.66M 10-Q · filed 2016-11-07 | $51.15M derived: sum of 2 quarters · filed 2016-11-07 | $76.27M 10-Q · filed 2016-11-07 | $103.30M derived: sum of 4 quarters · filed 2017-03-14 |
| 2015-06-30 | $26.49M 10-Q · filed 2016-08-08 | $51.62M 10-Q · filed 2016-08-08 | $78.64M derived: sum of 3 quarters · filed 2017-03-14 | $104.83M derived: sum of 4 quarters · filed 2017-03-14 |
| 2015-03-31 | $25.13M 10-Q · filed 2016-05-05 | $52.15M derived: sum of 2 quarters · filed 2017-03-14 | $78.34M derived: sum of 3 quarters · filed 2017-03-14 | $102.44M derived: sum of 4 quarters · filed 2017-03-14 |
| 2014-12-31 | $27.03M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | $53.21M derived: sum of 2 quarters · filed 2017-03-14 | $77.31M derived: sum of 3 quarters · filed 2017-03-14 | $104.38M 10-K · filed 2017-03-14 |
| 2014-09-30 | $26.18M 10-Q · filed 2015-11-05 | $50.28M derived: sum of 2 quarters · filed 2015-11-05 | $77.36M 10-Q · filed 2015-11-05 | $95.16M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | $24.10M 10-Q · filed 2015-08-10 | $51.17M 10-Q · filed 2015-08-10 | $68.97M derived: sum of 3 quarters · filed 2016-02-25 | $89.39M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | $27.07M 10-Q · filed 2015-04-29 | $44.87M derived: sum of 2 quarters · filed 2016-02-25 | $65.29M derived: sum of 3 quarters · filed 2016-02-25 | $80.38M derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | $17.80M derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-02-25 | $38.22M derived: sum of 2 quarters · filed 2016-02-25 | $53.31M derived: sum of 3 quarters · filed 2016-02-25 | $67.40M 10-K/A · filed 2016-02-25 |
| 2013-09-30 | $20.42M 10-Q · filed 2014-11-05 | $35.51M derived: sum of 2 quarters · filed 2014-11-05 | $49.60M 10-Q · filed 2014-11-05 | $63.34M derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-06-30 | $15.09M 10-Q · filed 2014-08-07 | $29.18M 10-Q · filed 2014-08-07 | $42.93M derived: sum of 3 quarters · filed 2015-02-24 | $54.70M derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-03-31 | $14.09M 10-Q · filed 2014-05-01 | $27.84M derived: sum of 2 quarters · filed 2015-02-24 | $39.61M derived: sum of 3 quarters · filed 2015-02-24 | $50.72M derived: sum of 4 quarters · filed 2015-02-24 |
| 2012-12-31 | $13.75M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $25.52M derived: sum of 2 quarters · filed 2015-02-24 | $36.63M derived: sum of 3 quarters · filed 2015-02-24 | $47.40M 10-K · filed 2015-02-24 |
| 2012-09-30 | $11.77M 10-Q · filed 2013-11-08 | $22.88M derived: sum of 2 quarters · filed 2013-11-08 | $33.65M 10-Q · filed 2013-11-08 | $43.48M derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-06-30 | $11.11M 10-Q · filed 2013-08-06 | $21.88M 10-Q · filed 2013-08-06 | $31.71M derived: sum of 3 quarters · filed 2014-03-03 | $40.30M derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-03-31 | $10.77M 10-Q · filed 2013-05-03 | $20.59M derived: sum of 2 quarters · filed 2014-03-03 | $29.19M derived: sum of 3 quarters · filed 2014-03-03 | $36.36M derived: sum of 4 quarters · filed 2014-03-03 |
| 2011-12-31 | $9.82M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $18.42M derived: sum of 2 quarters · filed 2014-03-03 | $25.59M derived: sum of 3 quarters · filed 2014-03-03 | $32.44M 10-K · filed 2014-03-03 |
| 2011-09-30 | $8.59M 10-Q · filed 2012-11-02 | $15.76M derived: sum of 2 quarters · filed 2012-11-02 | $22.61M 10-Q · filed 2012-11-02 | $29.36M derived: sum of 4 quarters · filed 2013-03-08 |
| 2011-06-30 | $7.17M 10-Q · filed 2012-08-09 | $14.02M 10-Q · filed 2012-08-09 | $20.76M derived: sum of 3 quarters · filed 2013-03-08 | $27.98M derived: sum of 4 quarters · filed 2013-03-08 |
| 2011-03-31 | $6.85M 10-Q · filed 2012-05-04 | $13.60M derived: sum of 2 quarters · filed 2013-03-08 | $20.81M derived: sum of 3 quarters · filed 2013-03-08 | $28.07M derived: sum of 4 quarters · filed 2013-03-08 |
| 2010-12-31 | $6.74M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-08 | $13.96M derived: sum of 2 quarters · filed 2013-03-08 | $21.21M derived: sum of 3 quarters · filed 2013-03-08 | $27.65M 10-K · filed 2013-03-08 |
| 2010-09-30 | $7.21M 10-Q · filed 2011-11-03 | $14.47M derived: sum of 2 quarters · filed 2011-11-03 | $20.91M 10-Q · filed 2011-11-03 | |
| 2010-06-30 | $7.26M 10-Q · filed 2011-08-04 | $13.69M 10-Q · filed 2011-08-04 | ||
| 2009-12-31 | $26.17M 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |